Commonwealth Biotechnologies Signs $1.5M in Biodefense Contracts for October | GenomeWeb

NEW YORK, Oct. 14 (GenomeWeb News) - R&D services firm Commonwealth Biotechnologies said today that it has signed $1.5 million in new biodefense-related contracts for October.

The company said that the contracts will support further development and validation of detection assays based on its mass spectrometry and DNA sequence analysis platforms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.